Example: Heart Attack

Clinical Trials Sponsored by Pfizer

Total 4991 results

NCT04557449

Not yet recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Conditions: Liposarcoma; CRC; Prostate Cancer; Breast Neoplasms; Adenocarcinoma of Lung; Solid Tumors
NCT04555278

Not yet recruiting

Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain

Conditions: Chronic Low-back Pain
NCT04555603

Not yet recruiting

Axitinib Therapy Management Study

Conditions: Renal Cell Carcinoma
NCT04552470

Not yet recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT04553133

Not yet recruiting

PF-07104091 as a Single Agent and in Combination Therapy

Conditions: Small Cell Lung Cancer; Ovarian Cancer; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Human Receptor-positive Human Epidermal Growth Factor Receptor 2
NCT04550936

Not yet recruiting

Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis

Conditions: Invasive Aspergillosis; Mucormycosis
NCT04549480

Not yet recruiting

Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition

Conditions: Healthy Participants
NCT04546425

Recruiting

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants

Conditions: Pneumococcal Disease
NCT04543188

Not yet recruiting

A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

Conditions: Malignant Melanoma; Carcinoma, Non-Small-Cell Lung; Brain Neoplasms, Primary; Brain Neoplasms; Malignant Neoplasms
NCT04543344

Not yet recruiting

Study To Evaluate The Pharmacokinetic, Safety And Tolerability Of Single Or Multiple Subcutaneous Doses of Recifercept

Conditions: Healthy
NCT04543357

Not yet recruiting

A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

Conditions: Household Contacts
NCT04541706

Recruiting

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Conditions: Advanced Non-Small Cell Lung Cancer
NCT04535167

Not yet recruiting

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending Dose And Extended Infusion of PF 07304814 In Hospitalized Participants With COVID-19.

Conditions: Viral Disease
NCT04535349

Not yet recruiting

Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

Conditions: Amyloidosis Transthyretin
NCT04530838

Not yet recruiting

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants

Conditions: Pneumococcal Disease
NCT04526574

Recruiting

Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age

Conditions: Pneumococcal Disease
NCT04516291

Not yet recruiting

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Conditions: Dyslipidemias; Hyperlipidemias; Hyperlipoproteinemias
NCT04517669

Not yet recruiting

Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

Conditions: Psoriatic Arthritis
NCT04517864

Not yet recruiting

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Conditions: Alopecia Areata
NCT04515589

Not yet recruiting

Central Aspects of Pain in Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT04511533

Not yet recruiting

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Conditions: Metastatic Non Small Cell Lung Cancer
NCT04511039

Not yet recruiting

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Conditions: Advanced Malignant Solid Neoplasm; Clinical Stage III Gastroesophageal Junction Adenocarcinoma; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma; Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma A; Locally Advanced Colorectal Carcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Metastatic Colorectal Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma; Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma; Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8
NCT04507763

Not yet recruiting

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Conditions: Ankylosing Spondylitis
NCT04507776

Not yet recruiting

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Conditions: Spondyloarthrosis
NCT04505410

Not yet recruiting

A Fasting Mimicking Diet on Ulcerative Colitis Patients Undergoing Tofacitinib Induction

Conditions: Ulcerative Colitis
NCT04498403

Not yet recruiting

A Phase 3, Multicenter, Open-Label Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Conditions: Atopic Dermatitis
NCT04498481

Completed

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Conditions: Breast Cancer
NCT04498520

Not yet recruiting

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Hormone Receptor Positive Breast Carcinoma; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Metastatic Endometrioid Adenocarcinoma; Metastatic Fallopian Tube Carcinoma; Metastatic HER2 Negative Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Ovarian Carcinoma; Metastatic Primary Peritoneal Carcinoma; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Refractory Breast Carcinoma; Stage IV Fallopian Tube Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Primary Peritoneal Cancer AJCC v8; Stage IV Uterine Corpus Cancer AJCC v8; Stage IVA Fallopian Tube Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Primary Peritoneal Cancer AJCC v8; Stage IVA Uterine Corpus Cancer AJCC v8; Stage IVB Fallopian Tube Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Primary Peritoneal Cancer AJCC v8; Stage IVB Uterine Corpus Cancer AJCC v8
NCT04494958

Not yet recruiting

Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer

Conditions: Triple Negative Breast Cancer
NCT04495140

Recruiting

Study To Characterize Mass Balance, Absolute Bioavailability, Fraction Absorbed And Pharmacokinetics Of 14C PF-06882961

Conditions: Healthy Volunteer
NCT04493203

Not yet recruiting

Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma

Conditions: Advanced Melanoma; Unresectable Melanoma
NCT04485325

Recruiting

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Conditions: Rheumatic Arthritis
NCT04486352

Not yet recruiting

A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer

Conditions: Endometrial Cancer
NCT04486625

Recruiting

Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

Conditions: Renal Insufficiency
NCT04483505

Not yet recruiting

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

Conditions: Breast Cancer Metastatic; Hormone Receptor Positive Malignant Neoplasm of Breast
NCT04484051

Not yet recruiting

Global Growth Hormone Study in Adults With Prader-Willi Syndrome

Conditions: Prader-Willi Syndrome
NCT04476563

Not yet recruiting

Checkpoint Inhibitor-induced Liver Injury

Conditions: Immune-Mediated Hepatitis
NCT04478305

Not yet recruiting

Affect of Duavive on Mood & Anxiety Symptoms

Conditions: Menopause; Depression, Anxiety; Sleep
NCT04478357

Recruiting

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Conditions: Neurogenic Detrusor Overactivity
NCT04469114

Not yet recruiting

Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia

Conditions: Covid19
NCT04460898

Completed

RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.

Conditions: Breast Cancer
NCT04460911

Active, not recruiting

Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

Conditions: Breast Cancer
NCT04456959

Recruiting

InO - A Retrospective Study of UK Patients With Leukaemia

Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma
NCT04458259

Not yet recruiting

A Study of PF-07265807 In Participants With Advanced or Metastatic Solid Tumors

Conditions: Neoplasm Metastasis
NCT04459169

Not yet recruiting

Cardiac Amyloidosis : Diagnostic Using Red Flag Signals

Conditions: Cardiac Amyloidosis
NCT04459767

Recruiting

Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides

Conditions: Healthy
NCT04456582

Recruiting

Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Bidimensional Shear Wave Elastography) in Patients With Transthyretin Amyloidosis

Conditions: Amyloidosis
NCT04452838

Recruiting

Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer

Conditions: Neurogenic Detrusor Overactivity
NCT04447521

Not yet recruiting

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium

Conditions: Pneumonia; Otitis Media; Sinusitis Bacterial
NCT04446039

Not yet recruiting

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Conditions: Major Depression

COOKIE SETTINGS

Clinical Trials Sponsored by Pfizer